Canaccord Genuity Maintains Buy on Enovis, Raises Price Target to $71
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Kyle Rose has maintained a Buy rating on Enovis (NYSE:ENOV) and increased the price target from $65 to $71.

December 20, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Kyle Rose reaffirmed a Buy rating on Enovis and raised the price target from $65 to $71, indicating a positive outlook on the stock.
The increase in price target by Canaccord Genuity suggests a bullish stance on Enovis, likely due to positive developments or expectations for the company's future performance. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100